Both in Pharmaceuticals
Boundless Bio vs Citius Oncology
Over the past year BOLD returned +84.6% and CTOR returned −65.2%; their daily moves had a correlation of 0.08.
BOLD +84.6% CTOR −65.2%Growth of $1, one year, split-adjusted
| Metric | BOLD | CTOR |
|---|---|---|
| Price | $2.40 | $0.5470 |
| Market cap | $55.5M | $57.9M |
| Today | +0.84% | −0.55% |
| 1 month | −6.6% | −35.6% |
| 6 months | +51.9% | −39.8% |
| Year to date | +100.0% | −45.3% |
| 1 year | +75.2% | −67.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.1× |
| Net cash | $72.6M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 31.5% | 98.9% |
| Short % of float | 7.0% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).